| J3245 | Injection, tildrakizumab, 1 mg | 4,500 | $110 | $495K |
| Q4159 | Affinity, per square centimeter (add-on, list separately in addition to primary procedure) | 650 | $320 | $210.9K |
| J7308 | Aminolevulinic acid HCl for topical administration, 20%, single unit dosage form (354 mg) | 300 | $310 | $91.5K |
| Q4196 | Puraply am, per square centimeter (add-on, list separately in addition to primary procedure) | 870 | $90 | $73.8K |
| 96574 | This code is used to report removal of hyperkeratotic (hardened, dry, scaly) skin lesions that appear precancerous followed by photodynamic therapy that exposes a lesion treated with a… | 310 | $200 | $59.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 760 | $50 | $39.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $80 | $37.9K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 750 | $40 | $26.4K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 320 | $70 | $22.7K |
| 17003 | In this add–on procedure, the provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code is appropriate for the second through… | 2,980 | $10 | $14.9K |